$1388.06
-29.93-2.11%
Last update: Nov 5, 1:03 PM
Eli Lilly and Co
LLYNYSE
The average analyst price target for Eli Lilly is $1,350.83, 2.7% below the current price. Of 22 analysts, 21 rate it Buy and 1 Hold. Targets range from $830 to $1,650. The latest change came on Nov 2, 2026, when Cantor Fitzgerald raised its price target on Eli Lilly from $1,440 to $1,600 and kept an Overweight rating.
Price Target Range — 9 Quarters
Analyst Consensus — 22 Analysts
Rating Trend — Last 9 Months
